×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NTRA – natera, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NTRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
6/24
04:35 am
ntra
Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target [Yahoo! Finance]
Low
Report
Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target [Yahoo! Finance]
6/21
08:36 am
ntra
Is Labcorp Holdings Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Labcorp Holdings Stock Outperforming the Dow? [Yahoo! Finance]
6/4
11:02 am
ntra
Natera's Signatera test to be covered under Medicare [Seeking Alpha]
Low
Report
Natera's Signatera test to be covered under Medicare [Seeking Alpha]
6/4
07:00 am
ntra
Natera Announces Medicare Coverage for Signatera™ Genome
Medium
Report
Natera Announces Medicare Coverage for Signatera™ Genome
6/2
04:19 pm
ntra
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 [Yahoo! Finance]
Low
Report
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 [Yahoo! Finance]
6/2
04:05 pm
ntra
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
Low
Report
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
5/29
07:34 am
ntra
United States Non-Invasive Prenatal Testing Analysis Report 2025: Market to Triple to Reach $3.24 Billion by 2033 - Focus on Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome [Yahoo! Finance]
Medium
Report
United States Non-Invasive Prenatal Testing Analysis Report 2025: Market to Triple to Reach $3.24 Billion by 2033 - Focus on Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome [Yahoo! Finance]
5/27
07:53 am
ntra
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? [Yahoo! Finance]
Low
Report
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
6/20
09:35 pm
ntra
Form 4 Natera, Inc. For: May 15 Filed by: Rabinowitz Matthew
Low
Report
Form 4 Natera, Inc. For: May 15 Filed by: Rabinowitz Matthew
6/20
09:05 pm
ntra
Form 4 Natera, Inc. For: Jun 16 Filed by: Sheena Jonathan
Low
Report
Form 4 Natera, Inc. For: Jun 16 Filed by: Sheena Jonathan
6/18
04:27 pm
ntra
Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL
Low
Report
Form 144 Natera, Inc. Filed by: RABINOWITZ DANIEL
6/18
04:02 pm
ntra
Form 8-K Natera, Inc. For: Jun 12
Low
Report
Form 8-K Natera, Inc. For: Jun 12
6/18
10:50 am
ntra
Form 144 Natera, Inc. Filed by: Sheena Jonathan
Low
Report
Form 144 Natera, Inc. Filed by: Sheena Jonathan
6/16
01:00 pm
ntra
Form 144 Natera, Inc. Filed by: Sheena Jonathan
Low
Report
Form 144 Natera, Inc. Filed by: Sheena Jonathan
6/11
09:05 pm
ntra
Form 4 Natera, Inc. For: Jun 10 Filed by: Marcus Gail Boxer
Low
Report
Form 4 Natera, Inc. For: Jun 10 Filed by: Marcus Gail Boxer
6/10
02:22 pm
ntra
Form 144 Natera, Inc. Filed by: Marcus Gail Boxer
Low
Report
Form 144 Natera, Inc. Filed by: Marcus Gail Boxer
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Natera Provides Remote Access to Tests Without Requiring Live Office Visits
39.3%
5/9 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.590 ActVsEst 0.050 - Beat 22.3%
8/7 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.570 ActVsEst 0.090 - Beat 17.7%
4/6 Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives 11.2%
3/4 Form S-8 Natera, Inc. 9.9%
3/12 Form 8-K Natera, Inc. For: Mar 06 8.8%
1/15 Form 4 Natera, Inc. For: Jan 13 Filed by: Rabinowitz Matthew 7.6%
2/26 Q4/2019 12/31/2019 EPS -0.460 ZacksConsensus -0.600 ActVsEst 0.140 - Beat 7.1%
8/22 Panorama NIPT Achieves 2 Million Test Milestone 6.6%
9/11 Form 4 Natera, Inc. For: Sep 09 Filed by: Brophy Michael Burkes 6.4%
5/9 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.590 ActVsEst 0.050 - Beat 22.3%
8/7 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.570 ActVsEst 0.090 - Beat 17.7%
4/6 Coverage for Natera's Panorama® Prenatal Test Extended by Greater Than 20 Million Lives 11.2%
3/4 Form S-8 Natera, Inc. 9.9%
3/12 Form 8-K Natera, Inc. For: Mar 06 8.8%
1/15 Form 4 Natera, Inc. For: Jan 13 Filed by: Rabinowitz Matthew 7.6%
2/26 Q4/2019 12/31/2019 EPS -0.460 ZacksConsensus -0.600 ActVsEst 0.140 - Beat 7.1%
8/22 Panorama NIPT Achieves 2 Million Test Milestone 6.6%
9/11 Form 4 Natera, Inc. For: Sep 09 Filed by: Brophy Michael Burkes 6.4%
TOP News Decliners
8/5
Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies
-14.6%
3/6 Natera, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -13.1%
3/31 Form 4 Natera, Inc. For: Mar 27 Filed by: Rabinowitz Matthew -12.7%
3/11 Form 4 Natera, Inc. For: Mar 09 Filed by: Chapman Steven Leonard -8.7%
3/18 Form SEC STAFF LETTER Natera, Inc. -8.4%
4/13 Natera Announces Preliminary First Quarter 2020 Financial Results -7.8%
8/13 Form 4 Natera, Inc. For: Aug 09 Filed by: BOTHA ROELOF -7.7%
9/6 Form 4 Natera, Inc. For: Sep 04 Filed by: Brophy Michael Burkes -7.6%
10/15 Form S-3ASR Natera, Inc. -7.4%
2/27 Natera Inc (NASDAQ: NTRA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $49.00 price target on the stock, up previously from $45.00. -5.6%
3/6 Natera, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -13.1%
3/31 Form 4 Natera, Inc. For: Mar 27 Filed by: Rabinowitz Matthew -12.7%
3/11 Form 4 Natera, Inc. For: Mar 09 Filed by: Chapman Steven Leonard -8.7%
3/18 Form SEC STAFF LETTER Natera, Inc. -8.4%
4/13 Natera Announces Preliminary First Quarter 2020 Financial Results -7.8%
8/13 Form 4 Natera, Inc. For: Aug 09 Filed by: BOTHA ROELOF -7.7%
9/6 Form 4 Natera, Inc. For: Sep 04 Filed by: Brophy Michael Burkes -7.6%
10/15 Form S-3ASR Natera, Inc. -7.4%
2/27 Natera Inc (NASDAQ: NTRA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $49.00 price target on the stock, up previously from $45.00. -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: